Gilles Salles

Lymphoma Service, Chief

Memorial Sloan Kettering Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gilles Salles is the Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center in the United States. His research focuses on clinical trials in lymphoma, particularly in the areas of large B-cell lymphoma and novel therapies such as chimeric antigen receptor T-cell treatments. He has published extensively on the outcomes of new treatment strategies and the comparative efficacy of therapeutic approaches in the field of hematologic malignancies.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Georg Hess

GERMANY

View details

Joshua Brody

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Eva Hoster

University Hospital, LMU Munich

GERMANY

View details

Stephen Schuster

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research

Hospital of the University of Pennsylvania

UNITED STATES

View details

Matthew Matasar

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Piers Patten

King’s College London

UNITED KINGDOM

View details

Jan Walewski

Head of the Dept., Director of the Institute

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Amitkumar Mehta

Assistant professor

The University of Alabama

UNITED STATES

View details

Paul M. Barr

University of Rochester

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gilles Salles

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma

Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell–Eligible and –Naive Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma

The current landscape of frontline large B-cell lymphoma trials

Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial

A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study

High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting

Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England

Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

Collaborators (9)

Georg Hess

Joshua Brody

Eva Hoster

Stephen Schuster

Matthew Matasar

Piers Patten

Jan Walewski

Amitkumar Mehta

Paul M. Barr

Make your next move.